Abstract This study employed surface-based properties for use in the superimposition of three series of molecules. The properties used were derived from semiempirical molecular orbital calculations and can be related to the physics of intermolecular interactions. In each case, the superimposition of the compounds was within 0.6 Ã… of the experimental overlay. The superimposition cases presented differing levels of involvement of electrostatic interactions, and in only one case did shape similarity provide the best overlay. Two test compounds were applied to an example exploring non-nucleoside HIV-1 reverse transcriptase inhibitors and only one of these compounds overlaid in the same manner as their crystal structure complexes. This served to highlight the need for molecules to occupy the same region of space when employing this technique. Nevertheless, the method can be used to generate pharmacophores and ultimately could be used to interrogate databases for molecules that match the key surface properties, thus allowing scaffold hopping. FigureDiagram showing the experimental overlay of the substructures of dihydrofolic acid (cyan) and methotrexate (magenta) (a) and their overlap using local electron affinity (EAL) (b)
reverse transcriptase inhibitors1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Reverse-transcriptase_inhibitor

intermolecular interactions   0.7481207291887025^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Chemical_bond         

HIV-1                         0.8441575630805013^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/HIV                   

molecular orbital             0.9999999999831743^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Molecular_orbital     

molecules                     0.6808910964728728^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Molecule              

methotrexate                  1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Methotrexate          

crystal structure             0.8599329025336975^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/X-ray_crystallography 

physics                       0.9997466017535128^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Physics               

electrostatic interactions    0.9961707913943306^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Electrostatics        

magenta                       0.9997681152586746^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Magenta               

EAL                           0.9984017928675798^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/English_as_a_second_or_foreign_language

molecules                     0.6808910964728728^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Molecule              

semiempirical                 0.9999999999984084^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Computational_chemistry

pharmacophores                1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Pharmacophore         

electron affinity             1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Electron_affinity     

molecules                     0.6808910964728728^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Molecule              

cyan                          1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Cyan                  

dihydrofolic acid             0.9999998481039372^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Folic_acid            

